Creo Medical Group PLC (AIM: CREO)

Creo Medical Group Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	9.8	3	13.1	43.53	45.09	81.05
Short-Term Investments	-	15.5	-	-	-	-
Cash & Short-Term Investments	9.8	18.5	13.1	43.53	45.09	81.05
Cash Growth	-63.02%	41.22%	-69.91%	-3.46%	-44.36%	81.77%
Accounts Receivable	9.9	6.4	5	3.88	4.24	-
Other Receivables	3.9	4.2	5.2	4.88	3.1	4.08
Receivables	13.8	10.6	10.2	8.76	7.33	4.08
Inventory	8.5	8.1	9.3	8.5	6.81	0.73
Prepaid Expenses	-	0.7	1.1	0.37	0.23	0.24
Total Current Assets	32.1	37.9	33.7	61.17	59.47	86.09
Property, Plant & Equipment	8.5	8.5	9.7	8.6	3.38	1.3
Long-Term Investments	2.1	2.7	2.6	1.73	0.5	-
Goodwill	18.7	19.1	19.6	18.56	18.26	-
Other Intangible Assets	6.5	6.8	7.8	8.33	9.78	0.75
Long-Term Deferred Tax Assets	1.2	1.1	1.5	1.71	0.47	-
Long-Term Deferred Charges	-	0.3	0.2	0.36	0.49	0.12
Other Long-Term Assets	0.2	0.2	0.1	0.15	0.11	0.01
Total Assets	69.3	76.6	75.2	100.61	92.46	88.26
Accounts Payable	5.4	2.5	4.3	3.54	2.46	0.92
Accrued Expenses	-	2.5	4.1	5.18	4.19	3.92
Short-Term Debt	3.5	2	3.8	3.32	3.34	-
Current Portion of Long-Term Debt	-	0.5	1.2	1.39	1.85	-
Current Portion of Leases	-	0.6	0.6	0.67	0.62	0.17
Other Current Liabilities	1	1.8	3.4	5.63	5.56	0.04
Total Current Liabilities	9.9	9.9	17.4	19.74	18.03	5.06
Long-Term Debt	10.7	4.4	4.9	3.79	5.16	0.36
Long-Term Leases	-	0.8	1.2	1.39	1.39	0.19
Long-Term Deferred Tax Liabilities	1	1.4	2	1.79	2	-
Other Long-Term Liabilities	0.3	0.3	0.4	0.59	3.09	-
Total Liabilities	21.9	16.8	25.9	27.29	29.66	5.6
Common Stock	0.4	0.4	0.2	0.18	0.16	0.15
Additional Paid-In Capital	180.9	180.9	149.5	149.45	115.26	115.11
Retained Earnings	-156.7	-144.4	-122.7	-95.76	-71.17	-50.85
Comprehensive Income & Other	22.8	22.9	22.3	19.45	18.55	18.25
Total Common Equity	47.4	59.8	49.3	73.32	62.81	82.66
Shareholders' Equity	47.4	59.8	49.3	73.32	62.81	82.66
Total Liabilities & Equity	69.3	76.6	75.2	100.61	92.46	88.26
Total Debt	14.2	8.3	11.7	10.56	12.36	0.72
Net Cash (Debt)	-4.4	10.2	1.4	32.98	32.74	80.33
Net Cash Growth	-	628.57%	-95.75%	0.74%	-59.25%	81.93%
Net Cash Per Share	-0.01	0.03	0.01	0.20	0.21	0.66
Filing Date Shares Outstanding	361.66	351.25	181.38	178.1	157.89	150.38
Total Common Shares Outstanding	361.66	351.25	181.38	178.1	157.89	150.38
Working Capital	22.2	28	16.3	41.43	41.44	81.04
Book Value Per Share	0.13	0.17	0.27	0.41	0.40	0.55
Tangible Book Value	22.2	33.9	21.9	46.42	34.77	81.92
Tangible Book Value Per Share	0.06	0.10	0.12	0.26	0.22	0.54
Land	-	4.6	4.6	4.51	-	-
Machinery	-	6.2	6	5.11	3.78	1.52
Construction In Progress	-	0.1	1.4	0.15	0.03	0.24
Leasehold Improvements	-	2.6	0.9	0.74	0.7	0.57

Source: S&P Capital IQ. Standard template. Financial Sources.